Marapharm Ventures Inc. "Marapharm" Announces that one License has Received Final Approval From the State of Nevada to Cultivate and Sell Cannabis

KELOWNA, British Columbia, May 25, 2017

Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2MO) ("Marapharm" or the "Company") (http://www.marapharm.com/) announces that the final and approved license in the State of Nevada allows it to grow and to sell cannabis and to purchase plants from other licensed growers. Plants will be purchased immediately. Accordingly, in addition to the license to grow and sell medical marijuana, this license is now positioned to make application for recreational marijuana licensing. To qualify for this, a license holder is to complete a taxable transaction on or before May 31, 2017.

ABOUT MARAPHARM VENTURES INC.

http://www.marapharm.com

Marapharm has 300,000 square feet of medical marijuana licenses for its land and facilities in WA and NV. About three years ago, Marapharm applied in Canada to Health Canada for a MMPR (production and sales) license and has passed the necessary security clearances. The application is currently in the in-depth screening process. In September 2016, Health Canada contacted Marapharm with a provision to amend its application to allow for the new regulations, ACMPR.

Marapharms common shares are publicly traded in Canada, under the ticker symbol "MDM" on the Canadian Securities Exchange, and in the United States, under the ticker symbol "MRPHF" on the OTCQB, and in Europe, under the ticker symbol "2M0" on the FSE.

Additional information on the operations or financial results of Marapharm are included in reports on file with applicable securities regulatory authorities and may be accessed through the CSE website (http://www.thecse.com ), the OTC website (http://www.otcmarkets.com ), and the SEDAR website (http://www.sedar.com ) under the profile for Marapharm Ventures Inc.